Abstract:Previous studies have reported the stepwise nature of human immunodeficiency virus type 1 (HIV-1) entry and the pivotal role of coreceptor CCR5 and the gp41 N-terminal heptad repeat (NHR) region in this event. With this in mind, we herein report a dual-targeted drug compound featuring bifunctional entry inhibitors, consisting of a piperidine-4-carboxamide-based CCR5 antagonist, TAK-220, and a gp41 NHR-targeting fusion-inhibitory peptide, C34. The resultant chimeras were constructed by linking both pharmacophores with a polyethylene glycol spacer. One chimera, CP12TAK, exhibited exceptionally potent antiviral activity, about 40- and 306-fold over that of its parent inhibitors, C34 and TAK-220, respectively. In addition to R5-tropic viruses, CP12TAK also strongly inhibited infection of X4-tropic HIV-1 strains. These data are promising for the further development of CP12TAK as a new anti-HIV-1 drug. Results show that this strategy could be extended to the design of therapies against infection of other enveloped viruses.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00781?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00781</a>.HPLC method used for the purification of peptide compounds; HPLC method used for the analysis of peptide compounds; potential cytotoxicity of CP12TAK on CEMx174 5.25M7 and MT-2 cells; MALDI-TOF-MS and Analytical HPLC of designed peptides; <sup>1</sup>H and <sup>13</sup>C NMR spectra of small-molecule compounds; and ESI-TOF-MS spectra of small-molecule compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00781/suppl_file/jm1c00781_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00781/suppl_file/jm1c00781_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

ChemInform Abstract: N‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea and N′‐[2‐(1‐Cyclohexenyl)ethyl]‐N′‐[2‐(5‐chloropyridyl)]‐thiourea As Potent Inhibitors of Multidrug‐Resistant Human Immunodeficiency Virus‐1.

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

ChemInform Abstract: Improved Synthesis of 1‐[hexahydrocyclopenta [C]pyrrol‐2(1h)‐yl]‐3‐(4‐methylbenzenesulfonyl)urea.

ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

ChemInform Abstract: Synthesis and HIV‐1 Integrase Inhibition Activity of Some N‐Arylindoles.

ChemInform Abstract: Synthesis and Biological Evaluation of Novel Isopropanolamine Derivatives As Non‐Peptide Human Immunodeficiency Virus Protease Inhibitors.

ChemInform Abstract: A Selective Inhibitor of Escherichia Coli Prephenate Dehydratase.

Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

Synthesis of 1‐(alkoxymethyl)‐5‐benzyl‐6‐methyluracil As Potential Nonnucleoside HIV‐1 RT Inhibitors.

ChemInform Abstract: Three‐Component, One‐Pot Synthesis of Novel 2,4‐substituted 5‐azolylthiopyrimidine Library for Screening Against Antiinfluenza Virus A.

ChemInform Abstract: Convergent Synthesis of the Spiroketal Core of the HIV‐1 Protease Inhibitors the Didemnaketals.

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

ChemInform Abstract: Synthesis of a Peptidomimetic HCMV Protease Inhibitor Library.

ChemInform Abstract: Study on Disulfur‐Backboned Nucleic Acids. Part 3. Efficient Synthesis of 3′,5′‐dithio‐2′‐deoxyuridine and Deoxycytidine.

ChemInform Abstract: Synthesis of 1‐arylated Derivatives of 5‐fluorouracil As Potential Antitumor Drugs.

ChemInform Abstract: the Reaction of Dilithium Tetrachlorocuprate and Dilithium Tetrabromonickelate with Unsaturated Epoxides: the Preparation of Novel Analogues of the Antiviral Agent, Bromoconduritol.

A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region

ChemInform Abstract: Synthesis and Cytotoxicity of Novel 3-Amido-4-indolylmaleimide Derivatives.

2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies

ChemInform Abstract: Synthesis and Biological Evaluation of Novel N‐[3‐(4‐phenylpiperazin‐1‐yl)‐propyl]‐carboxamide Derivatives.

ChemInform Abstract: Novel 2,4,5‐trisubstituted Oxazole Derivatives: Synthesis and Antiproliferative Activity.